Large clinical trial by the centers for disease control and prevention, harvard pilgrim health care institute, hca healthcare and uci health identifies best strategy to prevent life-threatening health care-associated icu infections

Nashville, tenn. & orange, calif. & atlanta & boston--(business wire)--a large multi-state study by the centers for disease control and prevention, harvard pilgrim health care institute, hca healthcare and the university of california, irvine has found that a nasal antibiotic ointment, mupirocin, which is currently used daily for intensive care unit (icu) patients in only one-third of u.s. hospitals, is highly effective at preventing staphylococcus aureus infections in critically ill patients,.
HCA Ratings Summary
HCA Quant Ranking